Phaos Technology Enters Securities Purchase Agreement for Up to $10 Million

SINGAPORE, Oct. 01, 2026 /CourierPR/ -- Phaos Technology Holdings (Cayman) Limited, an advanced microscopy technology company headquartered in Singapore, has entered into a securities purchase agreement that could significantly bolster its financial capabilities. On September 28, 2026, the company announced it had signed a deal with High West Partners LLC, a California-based investment firm, to potentially raise up to US$10 million through the sale of its Class A ordinary shares.

Under the terms of the agreement, Phaos retains the right, but not the obligation, to sell shares to High West from time to time at prevailing market prices. The agreement is subject to certain conditions, which, once satisfied, will mark the commencement date of the deal. This date is expected to be the starting point for Phaos to begin selling shares, with the agreement set to expire 36 months from the commencement date.

Phaos, known for its innovative microscopy technology and software solutions, has positioned itself at the forefront of advanced optical technologies. The company’s commitment to innovation and excellence is evident in its ongoing efforts to expand its product offerings and enhance its market presence. By entering into this equity facility, Phaos aims to further its research and development initiatives, potentially accelerating its growth trajectory in the highly competitive technology sector.

The press release also includes a forward-looking statement, highlighting the inherent risks and uncertainties associated with such agreements. Phaos acknowledges that the actual results may differ from the expectations outlined in the forward-looking statements due to various factors, many of which are outside the company’s control. Specifically, the forward-looking statements are subject to known and unknown risks, uncertainties, assumptions, and other important factors, many of which are outside of Phaos’s control and could cause actual results to differ materially from the results discussed in the forward-looking statements.

This strategic move by Phaos underscores its commitment to leveraging financial resources to drive innovation and maintain its competitive edge in the advanced microscopy technology market. As the company continues to explore new opportunities, the equity facility with High West Partners LLC represents a significant step forward in its financial strategy. The agreement, which is dated as of September 28, 2026, and is subject to the terms, conditions, and limitations set out in the Purchase Agreement and the applicable NYSE listing rules, is a testament to Phaos’s ongoing efforts to strengthen its financial position and support its growth initiatives.

By entering into this agreement, Phaos Technology Holdings (Cayman) Limited aims to enhance its financial flexibility and support its research and development efforts, positioning itself for continued success in the advanced microscopy technology market. The company’s commitment to innovation and excellence is reflected in its ongoing efforts to expand its product offerings and enhance its market presence.